|
a/README.md |
|
b/README.md |
1 |
## A Denoised Multi-omics Integration Framework for Cancer Subtype Classification and Survival Prediction |
1 |
## A Denoised Multi-omics Integration Framework for Cancer Subtype Classification and Survival Prediction |
2 |
|
2 |
|
3 |
--- |
3 |
--- |
4 |
|
4 |
|
5 |
### What we do? |
5 |
### What we do? |
6 |
|
6 |
|
7 |
- We developed a new feature selection method, Feature Selection with Distribution (FSD), for multi-omics data denosing and feature selection. |
7 |
- We developed a new feature selection method, Feature Selection with Distribution (FSD), for multi-omics data denosing and feature selection. |
8 |
|
8 |
|
9 |
- We developed a biologically informed deep learning algorithm for multi-omics integration to predict cancer subtypes and patient survival. |
9 |
- We developed a biologically informed deep learning algorithm for multi-omics integration to predict cancer subtypes and patient survival. |
10 |
|
10 |
|
11 |
- Commonly used feature selection methods, ANOVA, RFE, LASSO, PCA, were incorporated for comparison. |
11 |
- Commonly used feature selection methods, ANOVA, RFE, LASSO, PCA, were incorporated for comparison. |
12 |
|
12 |
|
13 |
- Several machine learning and deep learning algorithms, including Random Forest, XGboost, SVM, DNN, MOGONET<sup>1</sup>, Moanna<sup>2</sup>, were integrated for multi-omics integration for cpmparison. MOGONET used graph convolutional networks for multi-omics integration, and Moanna is a Autoencoder-based neural network. |
13 |
- Several machine learning and deep learning algorithms, including Random Forest, XGboost, SVM, DNN, MOGONET<sup>1</sup>, Moanna<sup>2</sup>, were integrated for multi-omics integration for cpmparison. MOGONET used graph convolutional networks for multi-omics integration, and Moanna is a Autoencoder-based neural network. |
14 |
|
14 |
|
15 |
--- |
15 |
--- |
16 |
|
16 |
|
17 |
<div align=center> |
17 |
<div align=center>
|
18 |
<img src="https://github.com/BioAI-kits/AttentionMOI/blob/master/img/Figure1.jpg" /> |
18 |
<img src="https://github.com/BioAI-kits/AttentionMOI/blob/master/img/Figure1.jpg?raw=true" />
|
19 |
</div> |
19 |
</div> |
20 |
|
20 |
|
21 |
**Introduction of project**. The availability of high-throughput sequencing data create opportunities to comprehensively understand human diseases as well as challenges to train machine learning models using such high dimensions of data. Here, we propose a denoised multi-omics integration framework for cancer subtype classification and survival prediction. Firstly, a distribution based feature denosing algorithm, Feature Selection with Distribution (FSD), were designed to reduce dimensions of omics features. Secondly, we introduced a a multi-omics integration framework, Attention Multi-Omics Integration (AttentionMOI), which is inspired by the central dogma of biology. We demonstrated that FSD improved model performance either using single omics data or multi-omics data in 13 TCGA cancers for survival prediction and kidney cancer subtype identification. And our integration framework outperformed traditional artificial intellegnce models current multi-omics integration algorithms under high dimensions of features. Furthermore, FSD identisied features were related to cancer prognosis and could be considered as biomarkers. |
21 |
**Introduction of project**. The availability of high-throughput sequencing data create opportunities to comprehensively understand human diseases as well as challenges to train machine learning models using such high dimensions of data. Here, we propose a denoised multi-omics integration framework for cancer subtype classification and survival prediction. Firstly, a distribution based feature denosing algorithm, Feature Selection with Distribution (FSD), were designed to reduce dimensions of omics features. Secondly, we introduced a a multi-omics integration framework, Attention Multi-Omics Integration (AttentionMOI), which is inspired by the central dogma of biology. We demonstrated that FSD improved model performance either using single omics data or multi-omics data in 13 TCGA cancers for survival prediction and kidney cancer subtype identification. And our integration framework outperformed traditional artificial intellegnce models current multi-omics integration algorithms under high dimensions of features. Furthermore, FSD identisied features were related to cancer prognosis and could be considered as biomarkers. |
22 |
|
22 |
|
23 |
--- |
23 |
--- |
24 |
|
24 |
|
25 |
### Install |
25 |
### Install |
26 |
|
26 |
|
27 |
You can install programs and dependencies via pip. We recommend using conda to build a virtual environment with python version 3.9 or higher. |
27 |
You can install programs and dependencies via pip. We recommend using conda to build a virtual environment with python version 3.9 or higher. |
28 |
|
28 |
|
29 |
(optional) Create a virtual environment |
29 |
(optional) Create a virtual environment |
30 |
|
30 |
|
31 |
```bash |
31 |
```bash
|
32 |
conda create -n env_moi python=3.9 |
32 |
conda create -n env_moi python=3.9 |
33 |
|
33 |
|
34 |
conda activate env_moi # Activate the environment |
34 |
conda activate env_moi # Activate the environment
|
35 |
``` |
35 |
``` |
36 |
|
36 |
|
37 |
Install |
37 |
Install |
38 |
|
38 |
|
39 |
```bash |
39 |
```bash
|
40 |
pip install AttentionMOI |
40 |
pip install AttentionMOI
|
41 |
``` |
41 |
``` |
42 |
|
42 |
|
43 |
### Parameters |
43 |
### Parameters
|
44 |
|
44 |
|
45 |
After your installation is complete, your computer terminal will contain a `moi` command. This is the only interface to our program. You will use this command to build an omics model. |
45 |
After your installation is complete, your computer terminal will contain a `moi` command. This is the only interface to our program. You will use this command to build an omics model. |
46 |
|
46 |
|
47 |
First, you can execute the following command line to get detailed help information. |
47 |
First, you can execute the following command line to get detailed help information. |
48 |
|
48 |
|
49 |
``` |
49 |
```
|
50 |
moi -h |
50 |
moi -h
|
51 |
``` |
51 |
``` |
52 |
|
52 |
|
53 |
Then, we also introduce these parameters in the following documents: |
53 |
Then, we also introduce these parameters in the following documents: |
54 |
|
54 |
|
55 |
|
55 |
|
56 |
**1. Input** |
56 |
**1. Input** |
57 |
|
57 |
|
58 |
The input file format is described below, or you can refer to the reference data we provide (https://github.com/BioAI-kits/AttentionMOI/tree/master/AttentionMOI/example). |
58 |
The input file format is described below, or you can refer to the reference data we provide (https://github.com/BioAI-kits/AttentionMOI/tree/master/AttentionMOI/example). |
59 |
|
59 |
|
60 |
f | omic_file |
60 |
f | omic_file |
61 |
|
61 |
|
62 |
> REQUIRED: File path for omics files (should be matrix) |
62 |
> REQUIRED: File path for omics files (should be matrix) |
63 |
|
63 |
|
64 |
**NOTE:The file must be in csv format, such as rna.csv. Of course, it can be compressed with gz, such as rna.csv.gz.**. Example: The first line is the header, patient_id and gene (features) names. |
64 |
**NOTE:The file must be in csv format, such as rna.csv. Of course, it can be compressed with gz, such as rna.csv.gz.**. Example: The first line is the header, patient_id and gene (features) names. |
65 |
|
65 |
|
66 |
> patient_id,A1BG,A1CF,A2BP1,A2LD1,.... |
66 |
> patient_id,A1BG,A1CF,A2BP1,A2LD1,....
|
67 |
> |
67 |
>
|
68 |
> TCGA.KL.8323,3.3491,0.0,0.0,5.8939,.... |
68 |
> TCGA.KL.8323,3.3491,0.0,0.0,5.8939,....
|
69 |
> |
69 |
>
|
70 |
> TCGA.KL.8324,2.922,0.5557,0.5557,6.4226,.... |
70 |
> TCGA.KL.8324,2.922,0.5557,0.5557,6.4226,.... |
71 |
|
71 |
|
72 |
n | omic_name |
72 |
n | omic_name |
73 |
|
73 |
|
74 |
> REQUIRED: Omic names for omics files, should be the same order as the omics file |
74 |
> REQUIRED: Omic names for omics files, should be the same order as the omics file |
75 |
|
75 |
|
76 |
l | label_file |
76 |
l | label_file |
77 |
|
77 |
|
78 |
> REQUIRED: File path for label file |
78 |
> REQUIRED: File path for label file |
79 |
|
79 |
|
80 |
**NOTE:The file must be in csv format, such as label.csv. Of course, it can be compressed with gz, such as label.csv.gz.**. Example: The first line is the header, patient_id and label represent the sample name and sample classification label respectively. |
80 |
**NOTE:The file must be in csv format, such as label.csv. Of course, it can be compressed with gz, such as label.csv.gz.**. Example: The first line is the header, patient_id and label represent the sample name and sample classification label respectively. |
81 |
|
81 |
|
82 |
> patient_id,label |
82 |
> patient_id,label
|
83 |
> |
83 |
>
|
84 |
> TCGA.KL.8328,0 |
84 |
> TCGA.KL.8328,0
|
85 |
> |
85 |
>
|
86 |
> TCGA.KL.8339,0 |
86 |
> TCGA.KL.8339,0
|
87 |
> |
87 |
>
|
88 |
> TCGA.KM.8439,1 |
88 |
> TCGA.KM.8439,1
|
89 |
> |
89 |
>
|
90 |
> TCGA.KM.8441,1 |
90 |
> TCGA.KM.8441,1
|
91 |
> |
91 |
>
|
92 |
> TCGA.KM.8442,1 |
92 |
> TCGA.KM.8442,1 |
93 |
|
93 |
|
94 |
|
94 |
|
95 |
**2. Output** |
95 |
**2. Output** |
96 |
|
96 |
|
97 |
o | outdir |
97 |
o | outdir |
98 |
|
98 |
|
99 |
> OPTIONAL: Setting output file path, default=./output |
99 |
> OPTIONAL: Setting output file path, default=./output |
100 |
|
100 |
|
101 |
|
101 |
|
102 |
**3. Feature selection** |
102 |
**3. Feature selection** |
103 |
|
103 |
|
104 |
method |
104 |
method |
105 |
|
105 |
|
106 |
> OPTIONAL: Method of feature selection, choosing from ANOVA, RFE, LASSO, PCA, default is no feature selection |
106 |
> OPTIONAL: Method of feature selection, choosing from ANOVA, RFE, LASSO, PCA, default is no feature selection |
107 |
|
107 |
|
108 |
percentile |
108 |
percentile |
109 |
|
109 |
|
110 |
> OPTIONAL: Percent of features to keep for ANOVA (integer between 1-100), only used when using ANOVA, default=30 |
110 |
> OPTIONAL: Percent of features to keep for ANOVA (integer between 1-100), only used when using ANOVA, default=30 |
111 |
|
111 |
|
112 |
num_pc |
112 |
num_pc |
113 |
|
113 |
|
114 |
> OPTIONAL: Number of PCs to keep for PCA (integer), only used when using PCA, default=50 |
114 |
> OPTIONAL: Number of PCs to keep for PCA (integer), only used when using PCA, default=50 |
115 |
|
115 |
|
116 |
FSD |
116 |
FSD |
117 |
|
117 |
|
118 |
> OPTIONAL: Whether to use FSD to mitigate noise of omics. Default is not using FSD, and set --FSD to use FSD |
118 |
> OPTIONAL: Whether to use FSD to mitigate noise of omics. Default is not using FSD, and set --FSD to use FSD |
119 |
|
119 |
|
120 |
i | iteration |
120 |
i | iteration |
121 |
|
121 |
|
122 |
> OPTIONAL: The number of FSD iterations (integer), default=10 |
122 |
> OPTIONAL: The number of FSD iterations (integer), default=10 |
123 |
|
123 |
|
124 |
s | seed |
124 |
s | seed |
125 |
|
125 |
|
126 |
> OPTIONAL: Random seed for FSD (integer), default=0 |
126 |
> OPTIONAL: Random seed for FSD (integer), default=0 |
127 |
|
127 |
|
128 |
threshold |
128 |
threshold |
129 |
|
129 |
|
130 |
> OPTIONAL: FSD threshold to select features (float), default=0.8 (select features that are selected in 80 percent FSD iterations) |
130 |
> OPTIONAL: FSD threshold to select features (float), default=0.8 (select features that are selected in 80 percent FSD iterations) |
131 |
|
131 |
|
132 |
|
132 |
|
133 |
**4. Building Model** |
133 |
**4. Building Model** |
134 |
|
134 |
|
135 |
m | model |
135 |
m | model |
136 |
|
136 |
|
137 |
> OPTIONAL: Model names, choosing from DNN, Net (Net for AttentionMOI), RF, XGboost, svm, mogonet, moanna, default=DNN. |
137 |
> OPTIONAL: Model names, choosing from DNN, Net (Net for AttentionMOI), RF, XGboost, svm, mogonet, moanna, default=DNN. |
138 |
|
138 |
|
139 |
t | test_size |
139 |
t | test_size |
140 |
|
140 |
|
141 |
> OPTIONAL: Testing dataset proportion when split train test dataset (float), default=0.3 (30 percent data for testing) |
141 |
> OPTIONAL: Testing dataset proportion when split train test dataset (float), default=0.3 (30 percent data for testing) |
142 |
|
142 |
|
143 |
b | batch |
143 |
b | batch |
144 |
|
144 |
|
145 |
> OPTIONAL: Mini-batch number for model training (integer), default=32 |
145 |
> OPTIONAL: Mini-batch number for model training (integer), default=32 |
146 |
|
146 |
|
147 |
e | epoch |
147 |
e | epoch |
148 |
|
148 |
|
149 |
> OPTIONAL: Epoch number for model training (integer), default=300 |
149 |
> OPTIONAL: Epoch number for model training (integer), default=300 |
150 |
|
150 |
|
151 |
r | lr |
151 |
r | lr |
152 |
|
152 |
|
153 |
> OPTIONAL: Learning rate for model training(float), default=0.0001 |
153 |
> OPTIONAL: Learning rate for model training(float), default=0.0001 |
154 |
|
154 |
|
155 |
w | weight_decay |
155 |
w | weight_decay |
156 |
|
156 |
|
157 |
> OPTIONAL: weight_decay parameter for model training (float), default=0.0001 |
157 |
> OPTIONAL: weight_decay parameter for model training (float), default=0.0001 |
158 |
|
158 |
|
159 |
--- |
159 |
--- |
160 |
|
160 |
|
161 |
### Example |
161 |
### Example |
162 |
|
162 |
|
163 |
Example (Data can be downloaded from https://github.com/BioAI-kits/AttentionMOI ): |
163 |
Example (Data can be downloaded from https://github.com/BioAI-kits/AttentionMOI ):
|
164 |
``` |
164 |
```
|
165 |
moi -f GBM_exp.csv.gz -f GBM_met.csv.gz -f GBM_logRatio.csv.gz -n rna -n met -n cnv -l GBM_label.csv --FSD -m Net -o GBM_Result |
165 |
moi -f GBM_exp.csv.gz -f GBM_met.csv.gz -f GBM_logRatio.csv.gz -n rna -n met -n cnv -l GBM_label.csv --FSD -m Net -o GBM_Result
|
166 |
``` |
166 |
``` |
167 |
|
167 |
|
168 |
--- |
168 |
--- |
169 |
|
169 |
|
170 |
### Ref. |
170 |
### Ref. |
171 |
|
171 |
|
172 |
1. MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification |
172 |
1. MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification |
173 |
|
173 |
|
174 |
2. Moanna: Multi-Omics Autoencoder-Based Neural Network Algorithm for Predicting Breast Cancer Subtypes |
174 |
2. Moanna: Multi-Omics Autoencoder-Based Neural Network Algorithm for Predicting Breast Cancer Subtypes |
175 |
|
175 |
|
176 |
|
176 |
|
177 |
--- |
177 |
--- |
178 |
|
178 |
|
179 |
All rights reserved. |
179 |
All rights reserved. |
180 |
|
180 |
|
181 |
|
181 |
|
182 |
|
182 |
|